Literature DB >> 12670394

Vav1: a key signal transducer downstream of the TCR.

Victor L J Tybulewicz1, Laurence Ardouin, Antonella Prisco, Lucinda F Reynolds.   

Abstract

Vav1 is a 95-kDa protein expressed in all hemopoietic cells that becomes rapidly tyrosine phosphorylated following T cell antigen receptor (TCR) stimulation. Vav1 contains multiple domains characteristic of signal transducing proteins, including a Dbl homology domain, a hallmark of a guanine nucleotide exchange factor (GEF) for Rho-family GTPases. Indeed Vav1 is a GEF for Rac1, Rac2 and RhoG, and it is activated following tyrosine phosphorylation. Generation of mice deficient in Vav1 has shown that it plays an important role in selection events within the thymus, including both positive and negative selection, consistent with Vav1 transducing TCR signals required to drive these processes. Furthermore, Vav1-deficient T cells are defective in TCR-induced proliferation and cytokine synthesis. Analysis of TCR signaling pathways in Vav1-deficient T cells and thymocytes has shown that Vav1 is required to transduce signals to the activation of a calcium flux, extracellular signal-regulated kinase (ERK) and the nuclear factor kappaB (NF-kappaB) transcription factor. Vav1 has also been shown to control the activation of phospholipase Cgamma1 (PLCgamma1) via both phosphoinositide-3-kinase (PI3K)-dependent and -independent pathways. Finally, Vav1 has been shown to transduce TCR signals to some but not all cytoskeleton-dependent pathways. In particular, Vav1 is required for efficient TCR-induced conjugate formation with antigen presenting cells (APCs), activation of the integrin leukocyte function-associated antigen-1 (LFA-1) and cell polarization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670394     DOI: 10.1034/j.1600-065x.2003.00032.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  42 in total

Review 1.  Signaling networks that regulate cell migration.

Authors:  Peter Devreotes; Alan Rick Horwitz
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-03       Impact factor: 10.005

2.  Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion.

Authors:  Rubén A Bartolomé; Isabel Molina-Ortiz; Rafael Samaniego; Paloma Sánchez-Mateos; Xosé R Bustelo; Joaquin Teixidó
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

3.  Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin alpha4beta1.

Authors:  David García-Bernal; Natalia Wright; Elena Sotillo-Mallo; César Nombela-Arrieta; Jens V Stein; Xosé R Bustelo; Joaquin Teixidó
Journal:  Mol Biol Cell       Date:  2005-05-04       Impact factor: 4.138

4.  Loss of Vav2 proto-oncogene causes tachycardia and cardiovascular disease in mice.

Authors:  Vincent Sauzeau; Mirjana Jerkic; José M López-Novoa; Xosé R Bustelo
Journal:  Mol Biol Cell       Date:  2007-01-03       Impact factor: 4.138

5.  Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins.

Authors:  Daniela Poppe; Imke Tiede; Gerhard Fritz; Christoph Becker; Brigitte Bartsch; Stefan Wirtz; Dennis Strand; Shinya Tanaka; Peter R Galle; Xosé R Bustelo; Markus F Neurath
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

6.  Endogenous RhoG is dispensable for integrin-mediated cell spreading but contributes to Rac-independent migration.

Authors:  Julia Meller; Luis Vidali; Martin Alexander Schwartz
Journal:  J Cell Sci       Date:  2008-05-27       Impact factor: 5.285

7.  Balanced Vav2 GEF activity regulates neurite outgrowth and branching in vitro and in vivo.

Authors:  Myung-soon Moon; Timothy M Gomez
Journal:  Mol Cell Neurosci       Date:  2010-03-16       Impact factor: 4.314

8.  Function of the nucleotide exchange activity of vav1 in T cell development and activation.

Authors:  Alexander Saveliev; Lesley Vanes; Olga Ksionda; Jonathan Rapley; Stephen J Smerdon; Katrin Rittinger; Victor L J Tybulewicz
Journal:  Sci Signal       Date:  2009-12-15       Impact factor: 8.192

Review 9.  Lymphocyte signaling: beyond knockouts.

Authors:  Alexander Saveliev; Victor L J Tybulewicz
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

10.  The use of knockout mice reveals a synergistic role of the Vav1 and Rasgrf2 gene deficiencies in lymphomagenesis and metastasis.

Authors:  Sergio Ruiz; Eugenio Santos; Xosé R Bustelo
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.